연구동향 분석

ORiginal Article : The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma

( Keun Hee Kang ) ( Ji Hoon Kim ) ( Seong Hee Kang ) ( Beom Jae Lee ) ( Yeon Seok Seo ) ( Hyung Joon Yim ) ( Jong Eun Yeon ) ( Jong Jae Park ) ( Jae Seon Kim ) ( Young Tae Bak ) ( Kwan Soo Byun ) 2015년

논문상세정보
인용/피인용
' ORiginal Article : The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • alcoholic
  • hepatocellularcarci-noma
  • liver diseases
  • prothrombin induced by vitamin k deficiency or antagonist ii
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,005 0

0.0%

' ORiginal Article : The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma' 의 참고문헌

  • 간세포암종 진단에 유의한 PIVKA-II 값의 제시 - ROC Curve를 이용하여 -
    김명진 Clinical and Molecular Hepatology 12 (3) : 404 ~ 411 [2006]
  • gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin
    Naraki T Biochim Biophys Acta 1586 : 287 ~ 298 [2002]
  • Vitamins K and D status in stages 3-5 chronic kidney disease
    Holden RM Clin J Am Soc Nephrol 5 : 590 ~ 597 [2010]
  • Vitamin K deficiency in chronic alcoholic males
    Iber FL Alcohol Clin Exp Res 10 : 679 ~ 681 [1986]
  • The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
    Mita Y Cancer 82 : 1643 ~ 1648 [1998]
  • The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin
    Grazi GL Liver Transpl Surg 1 : 249 ~ 255 [1995]
  • Studies on the mechanism of elevation of serum PIVKA-II levels in alcoholic liver cirrhosis
    Sakizono K Rinsho Byori 50 : 289 ~ 295 [2002]
  • Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group
    Ishii M Am J Gastroenterol 95 : 1036 ~ 1040 [2000]
  • Recent advances in hepatic vitamin K metabolism and function
    Suttie JW Hepatology 7 : 367 ~ 376 [1987]
  • Plasma prothrombin during treatment with Dicumarol. I. Immunochemical determination of its concentration in plasma
    Niléhn JE Scand J Clin Lab Invest 22 : 17 ~ 22 [1968]
  • Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma
    Tsai SL Hepatology 11 : 481 ~ 488 [1990]
  • Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma
    Takikawa Y J Gastroenterol Hepatol 7 : 1 ~ 6 [1992]
  • PIVKA-II-producing advanced gastric cancer
    Takano S Int J Clin Oncol 9 : 330 ~ 333 [2004]
  • Normotest and abnormal prothrombin in liver transplantation
    Nakao A Liver 15 : 260 ~ 264 [1995]
  • Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status
    Shearer MJ J Clin Pharmacol 28 : 88 ~ 95 [1988]
  • Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
    Okuda H Cancer 85 : 812 ~ 818 [1999]
  • Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients
    Umeki S Med Lab Sci 47 : 103 ~ 107 [1990]
  • Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma
    Ohhira M Alcohol Clin Exp Res 23 : 67S ~ 70S [1999]
  • In vivo effects of beta-lactam antibiotics and heterocyclic thiol compounds on vitamin K-dependent carboxylation activity and blood coagulation factors in vitamin K-deficient rats
    Oka T Biochem Pharmacol 37 : 2091 ~ 2095 [1988]
  • High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease
    Kuwabara A Osteoporos Int 20 : 935 ~ 942 [2009]
  • Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma
    Bertino G Minerva Med 102 : 363 ~ 371 [2011]
  • Determination of optimum cutoff levels of plasma des-gamma-carboxy prothrombin and serum alpha-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves
    Fujiyama S Tumour Biol 13 : 316 ~ 323 [1992]
  • Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer
    Kudo M Am J Gastroenterol 87 : 1859 ~ 1862 [1992]
  • Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
    Liebman HA N Engl J Med 310 : 1427 ~ 1431 [1984]
  • Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients
    Marrero JA Hepatology 37 : 1114 ~ 1121 [2003]
  • Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma
    Nakagawa T Int J Oncol 14 : 281 ~ 286 [1999]
  • Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes
    Kasahara A Dig Dis Sci 38 : 2170 ~ 2176 [1993]
  • Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-gamma-carboxyprothrombin
    Inagaki Y Liver Int 31 : 22 ~ 35 [2011]
  • Abnormal prothrombin in acute hepatic failure: the characterization and clinical evaluation
    Takikawa Y Nihon Shokakibyo Gakkai Zasshi 88 : 1074 ~ 1082 [1991]
  • A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma
    Ohhira M Alcohol Clin Exp Res 25 : 46S ~ 50S [2001]